Prognosis and treatment of COVID-19 infection while receiving treatment for comorbid active tuberculosis: 2 Case Reports

Tuberculosis (TB) is still a serious public health issue in underdeveloped nations. There is presently little clinical experience with the co-existence of tuberculosis (TB) and COVID-19 (coronavirus disease 19) infection, presented as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first observed in China in December 2019. This case report details the diagnostic and treatment stages of two patients who had active TB and COVID-19 infection, as well as the outcomes of their therapies, both of which were effective.